Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05441722 | CIPN in Early Stage Breast Cancer Patients | unknown | N/A | 48 | Northumbria UniversityOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06403904 | Assessing Clinical Features and Outcome of Breast Cancer in PALB2 Mutation Carriers: the Palbreast Study(PALBREAST) | unknown | — | 600 | Azienda Ospedaliero-Universitaria di ModenaOTHER | 1 | May 8, 2024 |
| NCT06403917 | Evaluation of Breast Cancer Screening Program at Assiut Governorate | unknown | — | 15,000,000 | Assiut UniversityOTHER | 0 | May 8, 2024 | clinicaltrials |
| NCT05297591 | Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment(UPLIFT-BC) | unknown | — | 250 | KU LeuvenOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT05371847 | Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity(UPLIFT-BC) | unknown | N/A | 150 | KU LeuvenOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT04527510 | Remote Breast Cancer Screening Study | unknown | — | 6,333 | The First Affiliated Hospital of the Fourth Military Medical UniversityOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT06392217 | clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases | unknown | — | 500 | Fudan UniversityOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT06385665 | The Effect of Appropriate Family Companionship on the Physical and Mental Health of Patients With Advanced Breast Cancer | unknown | N/A | 304 | Xin PengOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06334380 | VR for Surgical Prehabilitation and Rehabilitation(VR-PREP) | unknown | N/A | 30 | Stanford UniversityOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT05893368 | New Model for Integrating Person-based Care (PbC) in the Treatment of Advanced HER2-negative Breast Cancer(PERGIQUAL) | unknown | — | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT05982626 | Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer | unknown | N/A | 10 | Huashan HospitalOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT05989724 | A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors | unknown | Phase 1 | 150 | Qurgen Inc.INDUSTRY | 1 | Apr 24, 2024 | clinicaltrials |
| NCT06243432 | Estrogen Receptors and HER2 Levels' Expression in Luminal Metastatic Breast Cancer(CYCLHER) | unknown | — | 600 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT05695313 | Randomized Study Versus Placebo for the Prevention of Neurotoxicity Induced by Weekly PACLITAXEL(NEUROTAX) | unknown | Phase 2 | 60 | Centre Georges Francois LeclercOTHER | 1 | Apr 22, 2024 | clinicaltrials |
| NCT05939310 | Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study(MARGIN-2) | unknown | N/A | 70 | University Medical Center GroningenOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT06374628 | Pre-pectoral Tissue Expander and Acellular Dermal Matrix for a Two-stage Muscle Sparing Breast Reconstruction | unknown | — | 44 | Rossella Elia, MD PhDOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT00196833 | Breast Cancer in Pregnancy Register Study(BCP) | unknown | — | 1,100 | GBG Forschungs GmbHOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05084625 | PACED-digitized Support During Adjuvant Endocrine Therapy | unknown | N/A | 300 | Region StockholmOTHER_GOV | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05858242 | Study on Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast Cancer | unknown | — | 100 | Singlera Genomics Inc.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05925257 | Digital Health Intervention to Improve Health Care and Outcomes for Breast Cancer Patients | unknown | Phase 2 | 410 | Coordinación de Investigación en Salud, MexicoOTHER_GOV | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05659056 | Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer | unknown | Phase 2 | 65 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT06125834 | Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP Therapy | unknown | Phase 2 | 36 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT05145907 | Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors | unknown | Phase 2 | 133 | TJ Biopharma Co., Ltd.INDUSTRY | 1 | Apr 15, 2024 | clinicaltrials |
| NCT05919212 | Trastuzumab Deruxtecan (T-DXd): Tailoring Treatment and Companion Diagnostics (CDx) by Liquid Biopsy(DIAMOND) | unknown | N/A | 22 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06363123 | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | unknown | — | 2,700 | Beijing Friendship HospitalOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT05748353 | Endocrine Disruptors and Life STILe in Breast Cancer Development(STILVARCA) | unknown | — | 275 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT03635723 | Breast: Recovery After Axillary Node Clearance - Evaluating Limbs With E-Technology (the BRACELET Study)(BRACELET) | unknown | — | 75 | Imperial College LondonOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT03639948 | Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer(NeoPACT) | unknown | Phase 2 | 120 | University of Kansas Medical CenterOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT05467111 | Cardioprotective Effect of Acute Exercise in Breast Cancer Patients(CardioProtEx) | unknown | N/A | 40 | Technical University of MadridOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT06360809 | Prehabilitation Exercise Program in Breast Cancer: Effects on Quality of Life and Tumor Microenvironment (PEP_BC)(PEP_BC) | unknown | N/A | 76 | Institut Nacional d'Educacio Fisica de CatalunyaOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT06361264 | Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide | unknown | Early Phase 1 | 20 | KARANAHANOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT04469127 | A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients.(Heroine01) | unknown | Phase 1 / Phase 2 | 100 | Advanced Imaging Projects, LLCINDUSTRY | 2 | Apr 10, 2024 | clinicaltrials |
| NCT06356519 | Real-world Effectiveness and Safety Study of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer | unknown | — | 150 | Fudan UniversityOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT06357338 | Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma | unknown | — | 70 | Marwa Mahmoud HassanOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT04391543 | BIOpsychosocial Approach of the CAncer-RElated FAtigue (BIOCARE FActory) | unknown | N/A | 86 | Le Mans UniversiteOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06352684 | Multi-Reader Multi-Case, Retrospective Study to Evaluate Effectiveness of CadAI-B for Breast | unknown | — | 1,000 | BeamWorks Inc.INDUSTRY | 1 | Apr 8, 2024 | clinicaltrials |
| NCT05704842 | Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy | unknown | N/A | 40 | Virtua Health, Inc.OTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT06348654 | New Digital Person-based Care Model in Patients With HER2-negative Advanced Breast Cancer(InPERSON) | unknown | — | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | Apr 5, 2024 | clinicaltrials |
| NCT06182306 | Prospective Evaluation of AI R&D Tool for Patient Stratification - MoA Evaluation in Triple Negative Breast Cancer (PEAR-MET)(PEAR-MET) | unknown | — | 30 | Ourotech, Inc.INDUSTRY | 1 | Apr 3, 2024 | clinicaltrials |
| NCT06341842 | Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity(PROTECT) | unknown | Phase 2 | 316 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT06343181 | A Qualitative Study on Treatment Adherence in Patients With Metastatic Breast Cancer | unknown | — | 20 | European Institute of OncologyOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT05311618 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | unknown | Phase 1 | 71 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | Apr 1, 2024 | clinicaltrials |
| NCT06340165 | A Real-world Efficacy and Safety Study of Amlotinib for HER2-negative Advanced Breast Cancer | unknown | — | 153 | The First Hospital of Jilin UniversityOTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT06340386 | Italian Validation of a Tool for Assessing Sexual Function After Breast Cancer, FSFI-BC | unknown | — | 600 | European Institute of OncologyOTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT06338605 | Evaluating the Incidence of Pseudo-Acute Kidney Injuries in Patients With Metastatic Breast Cancer on CDK4/6 Inhibitors Trough Cystatin C Analysis(CYSTATINcDK4/6) | unknown | — | 40 | Erasmus Medical CenterOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT06338644 | Palbociclib in Metastatic Breast Cancer: Gene Polymorphism-based Study in Egyptian Patients.(Palbociclib) | unknown | — | 100 | Helwan UniversityOTHER | 0 | Mar 29, 2024 | clinicaltrials |
| NCT06334445 | CARDIOCARE Prospective Clinical Study(CARDIOCARE) | unknown | — | 736 | European Institute of OncologyOTHER | 1 | Mar 28, 2024 | clinicaltrials |
| NCT06327607 | Psychosexuological Interventions to Support Sexual Function in Breast Cancer Patients | unknown | — | 82 | European Institute of OncologyOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT06328387 | HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer | unknown | Phase 1 / Phase 2 | 120 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Mar 25, 2024 | clinicaltrials |
Data updated 23 days agoSource updated May 8, 2024source: clinicaltrials